Literature DB >> 18806279

Ability of antibodies to two new caliciviral vaccine strains to neutralise feline calicivirus isolates from the UK.

D Addie1, H Poulet, M C Golder, M McDonald, S Brunet, J-C Thibault, M J Hosie.   

Abstract

This study examined a panel of 110 UK field isolates of feline calicivirus (FCV) for susceptibility to cross-neutralisation by a panel of eight antisera raised in cats infected with FCV strains F9, 255, FCVG1 and FCV431. The pairs of antisera raised against F9 or 255, neutralised 20 and 21 per cent or 37 and 56 per cent of field strains of virus respectively. In contrast, the pairs of antisera raised against the newer vaccine strains FCVG1 or FCV431 neutralised 29 and 70 per cent or 67 and 87 per cent of field strains respectively. Antisera raised against the two newer strains, namely FCVG1 and FCV431, neutralised a greater proportion of field strains of calicivirus than antisera raised against the older FCV vaccine strains F9 and 255.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806279     DOI: 10.1136/vr.163.12.355

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  10 in total

Review 1.  Calicivirus Infection in Cats.

Authors:  Regina Hofmann-Lehmann; Margaret J Hosie; Katrin Hartmann; Herman Egberink; Uwe Truyen; Séverine Tasker; Sándor Belák; Corine Boucraut-Baralon; Tadeusz Frymus; Albert Lloret; Fulvio Marsilio; Maria Grazia Pennisi; Diane D Addie; Hans Lutz; Etienne Thiry; Alan D Radford; Karin Möstl
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

2.  Temporally separated feline calicivirus isolates do not cluster phylogenetically and are similarly neutralised by high-titre vaccine strain FCV-F9 antisera in vitro.

Authors:  Shirley L Smith; Maria M Afonso; Gina L Pinchbeck; Rosalind M Gaskell; Susan Dawson; Alan D Radford
Journal:  J Feline Med Surg       Date:  2019-08-14       Impact factor: 2.015

3.  Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge.

Authors:  Andrea M Spiri; Barbara Riond; Martina Stirn; Marilisa Novacco; Marina L Meli; Felicitas S Boretti; Imogen Herbert; Margaret J Hosie; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2021-07-30       Impact factor: 5.048

4.  Protective Efficacy of the Calicivirus Valency of the Leucofeligen Vaccine against a Virulent Heterologous Challenge in Kittens.

Authors:  Cynthia Lesbros; Virginie Martin; Wojciech Najbar; Annaele Sanquer; David McGahie; Hyone-Myong Eun; Sylvie Gueguen
Journal:  Vet Med Int       Date:  2013-06-20

5.  Ability of vaccine strain induced antibodies to neutralize field isolates of caliciviruses from Swedish cats.

Authors:  Jonas Johansson Wensman; Ayman Samman; Anna Lindhe; Jean-Christophe Thibault; Louise Treiberg Berndtsson; Margaret J Hosie
Journal:  Acta Vet Scand       Date:  2015-12-12       Impact factor: 1.695

6.  Feline calicivirus and other respiratory pathogens in cats with Feline calicivirus-related symptoms and in clinically healthy cats in Switzerland.

Authors:  Alice Berger; Barbara Willi; Marina L Meli; Felicitas S Boretti; Sonja Hartnack; Anou Dreyfus; Hans Lutz; Regina Hofmann-Lehmann
Journal:  BMC Vet Res       Date:  2015-11-13       Impact factor: 2.741

7.  European molecular epidemiology and strain diversity of feline calicivirus.

Authors:  J Hou; F Sánchez-Vizcaíno; D McGahie; C Lesbros; T Almeras; D Howarth; V O'Hara; S Dawson; A D Radford
Journal:  Vet Rec       Date:  2016-01-25       Impact factor: 2.695

8.  Use of vaccines and factors associated with their uptake variability in dogs, cats and rabbits attending a large sentinel network of veterinary practices across Great Britain.

Authors:  F Sánchez-Vizcaíno; A Muniesa; D A Singleton; P H Jones; P J Noble; R M Gaskell; S Dawson; A D Radford
Journal:  Epidemiol Infect       Date:  2018-04-11       Impact factor: 2.451

9.  Comparative efficacy of the Leucofeligen™ FeLV/RCP and Purevax™ RCP FeLV vaccines against infection with circulating feline Calicivirus.

Authors:  T Almeras; P Schreiber; S Fournel; V Martin; C S Nicolas; C Fontaine; C Lesbros; S Gueguen
Journal:  BMC Vet Res       Date:  2017-10-10       Impact factor: 2.741

10.  Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study.

Authors:  Andrea M Spiri; Marilisa Novacco; Marina L Meli; Martina Stirn; Barbara Riond; Jonathan E Fogle; Felicitas S Boretti; Imogen Herbert; Margaret J Hosie; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2021-08-31       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.